nalmefene associated_with insomnia
Evidence from:
primary |
all sources
Evidence (1 sources)
The adverse events reported most commonly with nalmefene (vs. placebo) were insomnia (13.4% vs. 5.4%)
confidence: 0.96
The adverse events reported most commonly with nalmefene (vs. placebo) were insomnia (13.4% vs. 5.4%)